It was the market maker's balance that likely included a trade because of the unusual size. It was not a buy. It was a sell at the bid: 37.41 Anyone with time and sales archive and does not suffer from color blindness can see this.
I wonder if Trump feels as good as you do when you insult someone. Perhaps it is just the thing dopes do. If you didn't comprehend the meaning of my post, then you need more than reading lessons. Thi not an 8 billion dollar company.
It is hard to determine just what is going on because there are so few free shares to drive the price up dramatically. I doubt they are close to any offer. If they were, there wouldn't be so many hedged shares. Until ADP, there isn't anything unknown about this company at this time. If they come up short on prescriptions, the stock could fall and we all know how quickly ACAD can fall. I don't think anything will move this stock before there is an ADP indication. It can't even hold above 37, which is where it was before the article. The article will have little effect on the price. Those who bought above 37 AH on Friday will bail if they can get their money back, having realized their mistake. I will be pleasantly surprised if it closes above 37.
They have made so much shorting against the box (50 to 17) that if it costs them a few bucks to get out of their shorts, it is no big deal. The Baker Brothers, for instance, are probably already locked in to at least a billion in profit.
You can bet your bottom dollar that the institutions have been shorting against the box. There aren't 22 million shares outside of their holdings. If ACAD is engaged in fielding serious buyout inquiries, yes, I am sure that the institutions know about them. That article was about as vague as it could be. Of course it is possible that a drug company made an inquiry about what price the Baker Brothers and Fidelity (which owns as much as the BB's) would entertain, but that is a far cry from an offer.
Why, buy under 45 when you can likely buy it under 36 today? It's only 36.31 at 5:45 EST. It is nothing but speculation. Institutions are clearly hedging with shorts against the box. From where else could 22 million short shares come? Don't you think institutions would know if a sale were near? Who do you think is the selling the company, the CEO? Do you think the Baker Brothers just told him to text them when a deal is found and done?.This is pure gossip. The blurb doesn't even bother to quote an "anonymous" source of "someone close to the situation." Calm down. Nothing will will happen before the end of the year or next.
nothing more. Remember when the stock ran to 50 because ACAD cancelled upcoming presentations and everyone thought it was because of a sale? Of course, if anyone stopped to think about it, why would an acquiring company want to interfere with a presentation. The problem with web based news outlets is that they have to fill space and there isn't enough factual news in the world to fill space so they speculate. ACAD isn't Genentech.
Never ask a dairy farmer how many cows he owns. It is as rude as asking to see his bank account.
Is not Seeking Alpha and his comments may well drive the share price down. Might be time to consider taking a breather and buying back when the dust settles.This is a company with great potential but could easily be seen as being ahead of itself in share price. It reminds me of early investment sin stem cell research and some of you may recall that didn't work out too well.
You replied: "I never said it was green. Money flow went negative to -38 million after the print. Check it yourself. IDRA/WSJ."
That explains why you removed the original message from the board where you wrote "it was green, you fool." I am not certain about this, but since money flow is a calculation based on volume and price of a traded stock within a defined period, an uptick on large volume would indicate positive money flow and a downtick on large volume would indicate negative money flow. I would say that downtick for 1/3 of Friday's volume, caused by the market maker's balance, would create the appearance of a negative cash flow and be recorded as such. The indisputable fact is that the MM balance did not influence the price of the stock, as you would expect a sale 2 cents below the bid for 1/3 of the day's volume would. Now, if you move quickly enough, perhaps you can remove this post from the board, as well.
The only potential stumbling block I see for ACAD is Medicare. It has done in other drugs, including the infamous Provenge from DNDN: an approved drug that actually prolonged life. Medicare can (I'm not saying it will) make it very difficult for physicians to put patients on some drugs, especially expensive ones.
The first reply seemed not to post, so I post again. You are just dead wrong: it was red, not green and I will send a screen shot of the last 30 minutes of trading from Fidelity's Active Trader Pro to anyone who sends me an email : email@example.com
It is clearly the market maker's balance at the end of the day, since no other high volume post appears at exactly 16:00:00. It was neither a buy nor a sell.
After looking at the 1.1 mil "trade again, I don't think it was a buy, sell or cover (buy) at all. I think it was simply a cumulative market maker's balancing of a few days. If you look at time and sales of any stock, you will always see an unusually large "trade" at exactly 16:00:00. That is the market maker's balancing. For instance, there is a 1,854,155 "trade in AAPL at 16:00:00 today. Check any stock and you will see this every day, without fail. It's just unusually large for ACAD today, but it is possible that with such a busy week and unusually high volume, they only got caught up today and, it being Friday, had to balance their account, like you balance your checkbook.
It was neither a cover nor a buy. It was a sale. If you had a color monitor, you would see that it was a trade 2 cents below the bid of 33.55, executed at 33.52 and it posted in RED! I am not bashing anyone or the stock. I just think that posts should be factual and not mixed with wishful thinking. Wishful thinking does not help any of us.